Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

Terumo Buys Vascular Therapy Biz Aortica

Terumo is acquiring the vascular therapy company to boost its AAA graft business.

M & A Deals

Thermo Fisher Scientific Partners With Breath Biopsy Firm Owlstone Medical

Thermo Fisher Scientific has signed a collaboration with Cambridge, UK-based Owlstone Medical to identify novel biomarkers.

Companies Deals

Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline

With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.

Cancer Diagnostics

Stryker Goes Shoulder To Shoulder With Wright Medical In $4Bn Takeover

Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. The agreement, announced on 4 November, is Stryker’s biggest acquisition this year.

M & A Deals

The Future Of AI Use In Endoscopy

Medtronic has launched a new artificial intelligence enhanced endoscopy system in Europe for recognizing pre-cancerous polyps. The gastroenterology community recently convened at an expert panel discussion hosted by Medtronic during UEG Week to discuss the future of AI in endoscopy.

Artificial Intelligence Commercial

J&J Team Up With China’s Tinavi; A Much Needed Boost For Spine Business?

A new co-marketing agreement with Chinese orthopedics group Tinavi could be key in turning round Johnson & Johnson’s spine business, according to executives. The collaboration will allow J&J’s DePuy Synthes business, to sell the TiRobot for spine and trauma surgery in the Chinese market.

Robotic Surgery Commercial
See All
UsernamePublicRestriction

Register